Smolyansky challenges Lifeway Foods' rights plan extension

Published 07/11/2025, 16:22
Smolyansky challenges Lifeway Foods' rights plan extension

CHICAGO - Lifeway Foods, Inc. (NASDAQ:LWAY) shareholders Edward and Ludmila Smolyansky, who control approximately 26% of outstanding shares, have criticized the company's decision to extend its Shareholder Rights Agreement without shareholder approval. The kefir producer, currently valued at $383 million with a price-to-earnings ratio of 35.8, maintains a strong financial position according to InvestingPro data, which rates the company's overall financial health as "GREAT."

On October 29, Lifeway's board approved a one-year extension of its Rights Plan to October 29, 2026, just before a scheduled board refreshment and leadership change deadline. The company also amended its bylaws to set the number of directors between five and ten.

Edward Smolyansky called the extension "a power grab that shields management and already entrenched directors at the expense of ordinary shareholders," according to a press release statement. The Smolyanskys argue the board should put the plan to a shareholder vote at the upcoming Annual Meeting.

The extension comes amid concentrated ownership by Danone SA, which holds approximately 23% of Lifeway's shares. The Smolyanskys have called on the company to rescind the amendment, disclose the board vote details, commit to shareholder votes on future renewals, and honor board refreshment promises.

The rights plan extension followed an October 17 letter from Edward Smolyansky notifying the company of his intent to nominate a candidate for the board and propose establishing a new committee of independent directors to evaluate executive management performance and strategic alternatives.

Lifeway Foods is scheduled to announce its third quarter results on November 12.

In other recent news, Lifeway Foods reported an estimated net sales growth of 21% to 24% for the third quarter of 2025, with sales expected to be between $55.8 million and $57.0 million. This increase is attributed to strong consumer demand for its kefir and farmer cheese product lines. Additionally, Lifeway Foods announced a strategic collaboration with Joe & The Juice to launch a limited-edition smoothie featuring its probiotic kefir, available at all Joe & The Juice U.S. locations. The company also extended its Shareholder Rights Agreement, commonly known as a "poison pill," by one year, now set to expire on October 29, 2026. Lifeway Foods has scheduled its 2025 annual shareholder meeting for December 16, with a deadline of October 20, 2025, for shareholder proposals. In board-related news, Jody Levy has resigned from the board of directors, with the company stating that the resignation was not due to any disagreements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.